If AMVAC Is Done Synthesizing, Why Is the Deadline Still December 31?
American Vanguard's chief executive called the Los Angeles closure complete on Monday afternoon. The 10-Q filed the same day keeps the December 31 deadline, and the two budget lines that pay for a plant to actually stop producing took nothing in the third quarter. Also new since Monday: Trinseo puts a Dutch latex plant in a press-release bullet its own 10-Q never mentions, Bayer hands back the tioxazafen technical, and Commerce decides a few percent of alumina is worth an inquiry.
You can read the quarterly report or you can listen to the call. Monday needed both.
American Vanguard filed its third-quarter 10-Q saying the Los Angeles plant reorganization "is expected to be completed by December 31, 2026." Its chief executive spent that afternoon telling analysts the rationalization of that facility "is complete."
"When the filing and the call disagree about whether a plant has stopped, which one is the capacity record?"
Everything below is new since Monday's radar. Two items sit in Thursday's Federal Register, already filed, because Veterans Day took Wednesday's issue out of the calendar.
The rest of this brief is for subscribers.
The capacity math, the trade-flow read, and what it means for the products you buy.
$50 a month, or $400 a year.
Already a subscriber? Sign in